2012
DOI: 10.1016/s0167-8140(12)72350-2
|View full text |Cite
|
Sign up to set email alerts
|

Po-384 Combined External Beam Radiotherapy and Intraluminal Brachytherapy in the Treatment of Esophageal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…More recently though, higher radiotherapy dose is being increasingly reported to improve the outcomes in esophageal cancer. [2][3][4][5][6][7][8] Radiotherapy dose escalation can be done either with external beam radiotherapy (EBRT) or using intraluminal brachytherapy (ILRT). ILRT in esophageal cancer offers an advantage of higher doses to the tumor while sparing the normal tissues and has been studied in combination with external radiotherapy-for both curative and palliative intents-by many researchers around the world.…”
Section: Introductionmentioning
confidence: 99%
“…More recently though, higher radiotherapy dose is being increasingly reported to improve the outcomes in esophageal cancer. [2][3][4][5][6][7][8] Radiotherapy dose escalation can be done either with external beam radiotherapy (EBRT) or using intraluminal brachytherapy (ILRT). ILRT in esophageal cancer offers an advantage of higher doses to the tumor while sparing the normal tissues and has been studied in combination with external radiotherapy-for both curative and palliative intents-by many researchers around the world.…”
Section: Introductionmentioning
confidence: 99%